Actinogen Medical Ltd banner

Actinogen Medical Ltd
ASX:ACW

Watchlist Manager
Actinogen Medical Ltd Logo
Actinogen Medical Ltd
ASX:ACW
Watchlist
Price: 0.037 AUD Market Closed
Market Cap: AU$128.1m

Wall Street
Price Targets

ACW Price Targets Summary
Actinogen Medical Ltd

Wall Street analysts forecast ACW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACW is 0.082 AUD with a low forecast of 0.081 AUD and a high forecast of 0.084 AUD.

Lowest
Price Target
0.081 AUD
118% Upside
Average
Price Target
0.082 AUD
121% Upside
Highest
Price Target
0.084 AUD
127% Upside
Actinogen Medical Ltd Competitors:
Price Targets
KRNY
Kearny Financial Corp
13% Upside
AREC
American Resources Corp
150% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
-2% Downside
QNST
Quinstreet Inc
68% Upside

Revenue
Forecast

22% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
22% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss

For the last 13 years the compound annual growth rate for Actinogen Medical Ltd's revenue is 22%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACW's stock price target?
Price Target
0.082 AUD

According to Wall Street analysts, the average 1-year price target for ACW is 0.082 AUD with a low forecast of 0.081 AUD and a high forecast of 0.084 AUD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett